In conclusion, we investigated, for the first time, ANGPTL-3 and ANGPTL-4 expression throughout the natural history of hepatitis C in vivo and long-term HCV infection in vitro and then determined the corresponding ANGPTL levels after treatment with DAAs. The gene discussed is ANGPTL3; the disease is hepatitis C virus infection.